DR. Rohit Swami

MD, DM (Medical Oncology)
Tata Memorial Hospital, Mumbai
Consultant Medical Oncology, Narayana Multispeciality Hospital, Jaipur

Dr. Rohit swami is a Senior Consultant Haematologist and Medical Oncologist in the Department of Medical Oncology at Narayana multispeciality Hospital in Jaipur, Rajasthan. After his MBBS from S.MS Medical College,
he obtained an MD in Internal Medicine from Gandhi Medical College, Bhopal. This was followed by senior residency in medical oncology from sabdargunj hospital , New Delhi. Subsequently,
Dr. Swami completed his DM Medical Oncology from Tata Memorial Hospital in Mumbai. He worked for 1 year as Specialist registrar/consultant at TMH ,Mumbai and worked as Senior consultant medical oncology for 6 months at Shalby hospital ,Jaipur before moving on to his current posting.Dr.Rohit Swami has contributed several theses and research papers in the field of oncology. His expertise includes treatment of all kinds of cancers,including solid tumors and blood cancers in both adults and paediatric population.

Education
  • MBBS - Swai Man Singh (SMS) Medical College, Jaipur, 2002 to 2008
  • MD (Gen. Med) - Gandhi Medical College, Bhopal, 2010 to 2013
  • DM (Med. Oncology) - Tata Memorial Hospital,Mumbai, 2014 to 2017
Fields of Expertise
  • All types of cancers, tumours
  • Solid Tumors & Blood Cancer
  • Pediatric solid Tumors, & Haemato Oncology
  • Chemotherapy, Targeted Therapy, Immunotherapy
  • Palliative Therapy
  • Bone Marrow Transplant
WORK EXPERIENCE:
  • Internship at SMS Medical College - Jaipur from Sept 2007 to August 2008
  • Post Graduate Residency in General Medicine at Gandhi Medical College, Bhopal – May 2010 to May 2013
  • Senior Residency in Medical Oncology at Sabdarjung Hospital, New Delhi - Jan 2014 to July 2014.
  • DM in Medical Oncology –August 2014- August 2017.
  • Consultant Medical Oncology – August 2017 till date
RESEARCH ACTIVITIES AT GRADUATE AND POST-GRADUATE LEVEL:
  • “Study of prognostic significance of serum creatinine phosphokinase in Acute Poisoning cases”.
  • “Prevalence of subclinical hypothyroidism is significantly higher in metabolic syndrome” ,Published in ISRA JIP
  • “Subclinical hypothyroidism in metabolic syndrome increases cardiovascular morbidity” ,Published in ISRA JIP
  • “Neuromyotonia :Clinical profile of ten cases from central India”
RESEARCH PROJECTS:
  • Validation and use of the Hurria score in predicting chemotherapy toxicity risk in elderly population undergoing chemotherapy for Breast, GI and Gynaecological cancers in Indian setup.
  • Prevalence of MMR status in locally advanced rectal cancer and its correlation with response to neoadjuvant therapy and survival.
  • Multimodality management of periampullary adenocarcinomas – prognostic factors and outcomes.
AFFILIATIONS:
  • Indian Society of Medical and Paediatric Oncology (ISMPO) – Member
  • American Society of Clinical Oncology (ASCO)-Full Member
PUBLICATIONS:
AWARDS AND PRESENTATIONS:
  • “Prevalence of subclinical hypothyroidism is significantly higher in metabolic syndrome”at 7TH National medicine update 2012, Bhopal, India
  • “Study of prognostic significance of serum creatine phosphokinase in Acute Poisoning cases” at 8th National medicine update 2013, Bhopal, India
  • “A randomised clinical trial evaluating the efficacy and safety of addition of oral metronomic chemotherapy after completion of standard chemo radiation versus observation in carcinoma oesophagus and gastro- oesophageal junction”.Presented at METRONOMICS @ MUMBAI 2016. 5th BIENNIAL INTERNATIONAL METRONOMIC & ANTI-ANGIOGENIC MEETING on 6-8 May 2016, in Mumbai, India
  • “Good response to metronomic cyclophosphamide for metastatic epitheloid hemangioendothelioma: case report” Presented at METRONOMICS @ MUMBAI 2016. 5th BIENNIAL INTERNATIONAL METRONOMIC & ANTI-ANGIOGENIC MEETING on 6-8 May 2016, in Mumbai, India.
  • “Gemcitabine–cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward”.Presented at 38th ICON meeting on 23-25 March 2018, inCochin, Kerala.

Oncology

Head & Neck Cancer

Read More

Throat Cancer

Read More

Breast Cancer

Read More

Gynecological Cancer

Read More

Gastrointestinal Cancer

Read More

Lung Cancer

Read More

Liver Cancer

Read More

Bone Cancer

Read More

Soft Tissue Tumour

Read More

Kidney Cancer

Read More

Urology Cancer

Read More

Prostate Cancer

Read More

Haematology

Read More